Vycor Medical (VYCO) Share-based Compensation Growth (3y) (2013 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 4.10% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 5.54% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 5.09% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 14.70% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 5.29% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 7.15% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 13.40% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 12.36% |
| 10 | Vycor Medical | - | - | 375,153.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -41.13% |
| Mar 31, 2025 | -63.98% |
| Dec 31, 2024 | -24.61% |
| Mar 31, 2024 | -73.17% |
| Dec 31, 2023 | -73.46% |
| Sep 30, 2023 | -73.47% |
| Jun 30, 2023 | -73.94% |
| Mar 31, 2023 | -71.62% |
| Dec 31, 2022 | -26.27% |
| Sep 30, 2022 | -23.47% |
| Jun 30, 2022 | -16.96% |
| Mar 31, 2022 | -27.65% |
| Dec 31, 2021 | -24.70% |
| Sep 30, 2021 | -14.93% |
| Jun 30, 2021 | -37.95% |
| Mar 31, 2021 | 67.89% |
| Dec 31, 2020 | 71.30% |
| Sep 30, 2020 | 4.16% |
| Jun 30, 2020 | -11.54% |
| Mar 31, 2020 | 198.88% |
| Dec 31, 2019 | -22.24% |
| Jun 30, 2019 | 63.58% |
| Mar 31, 2019 | -19.38% |
| Dec 31, 2018 | 30.63% |
| Sep 30, 2018 | 20.58% |
| Jun 30, 2018 | 87.71% |
| Mar 31, 2018 | -33.54% |
| Sep 30, 2017 | 23.57% |
| Jun 30, 2017 | 28.42% |
| Mar 31, 2017 | -69.05% |
| Dec 31, 2016 | 28.30% |
| Jun 30, 2016 | -38.52% |
| Mar 31, 2016 | 42.46% |
| Dec 31, 2015 | -0.63% |
| Sep 30, 2015 | 34.63% |
| Jun 30, 2015 | -3.17% |
| Mar 31, 2015 | -16.12% |
| Sep 30, 2014 | -72.13% |
| Jun 30, 2014 | 27.96% |
| Mar 31, 2014 | 41.11% |
| Dec 31, 2013 | 43.63% |
| Sep 30, 2013 | 34.00% |